Biomarker Study Completed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomarker Study Completed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomarker Study Completed Today - Breaking & Trending Today

NeuroSense CEO Provides Q1 2023 Update: Phase 2b ALS Trial Achieves 80% Enrollment

Published: April 17, 2023

/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...

Source: prnewswire.com

Related Topics:

United StatesUnited KingdomPrnewswire Neurosense Therapeutics LtdNeurosense Therapeutics LtdHospital Neuroepigenetics LabSense TherapeuticsAlon Ben NoonAmyotrophic Lateral SclerosisPatient EnrollmentTrial UnderBiomarker Study CompletedMassachusetts General HospitalNeuroepigenetics Lab